A review of cystic fibrosis: Basic and clinical aspects

被引:66
作者
Chen, Qionghua [1 ,2 ]
Shen, Yuelin [1 ]
Zheng, Jingyang [2 ]
机构
[1] Capital Med Univ, Beijing Childrens Hosp, Dept Resp Med 2, Natl Ctr Childrens Hlth, Beijing, Peoples R China
[2] Quanzhou Childrens Hosp, Dept Resp Med, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
animal model; CFTR; Chinese; clinical feature; cystic fibrosis; mutation; CHRONIC RHINOSINUSITIS; RAT MODELS; GENE; MUTATIONS; BIOLOGY;
D O I
10.1002/ame2.12180
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cystic fibrosis is an autosomal recessive disease caused by mutations of the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). Here we summarize, at the basic descriptive level, clinical and genetic characteristics of cystic fibrosis gene mutations, while emphasizing differences between CF mutations found in Chinese pediatric CF patients compared to those found in Caucasian CF patients. In addition, we describe animal models used to study human cystic fibrosis disease and highlight unique features of each model that mimic specific human CF-associated signs and symptoms. At the clinical level, we summarize CF clinical manifestations and diagnostic, treatment, and prognostic methods to provide clinicians with information toward reducing CF misdiagnosis and missed diagnosis rates.
引用
收藏
页码:220 / 232
页数:13
相关论文
共 64 条
[1]   NUCLEOSIDE TRIPHOSPHATES ARE REQUIRED TO OPEN THE CFTR CHLORIDE CHANNEL [J].
ANDERSON, MP ;
BERGER, HA ;
RICH, DP ;
GREGORY, RJ ;
SMITH, AE ;
WELSH, MJ .
CELL, 1991, 67 (04) :775-784
[2]   Longitudinal Cystic Fibrosis Care [J].
Antunovic, S. S. ;
Lukac, M. ;
Vujovic, D. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (01) :86-97
[3]   Consensus statement: Guide to bone health and disease in cystic fibrosis [J].
Aris, RM ;
Merkel, PA ;
Bachrach, LK ;
Borowitz, DS ;
Boyle, MP ;
Elkin, SL ;
Guise, TA ;
Hardin, DS ;
Haworth, CS ;
Holick, MF ;
Joseph, PM ;
O'Brien, K ;
Tullis, E ;
Watts, NB ;
White, TB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1888-1896
[4]   PURIFICATION AND FUNCTIONAL RECONSTITUTION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) [J].
BEAR, CE ;
LI, CH ;
KARTNER, N ;
BRIDGES, RJ ;
JENSEN, TJ ;
RAMJEESINGH, M ;
RIORDAN, JR .
CELL, 1992, 68 (04) :809-818
[5]  
Bear Christine E, 2020, Cell, V180, P211, DOI 10.1016/j.cell.2019.12.032
[6]   PANCREATIC INSUFFICIENCY, GROWTH, AND NUTRITION IN INFANTS IDENTIFIED BY NEWBORN SCREENING AS HAVING CYSTIC-FIBROSIS [J].
BRONSTEIN, MN ;
SOKOL, RJ ;
ABMAN, SH ;
CHATFIELD, BA ;
HAMMOND, KB ;
HAMBIDGE, KM ;
STALL, CD ;
ACCURSO, FJ .
JOURNAL OF PEDIATRICS, 1992, 120 (04) :533-540
[7]  
[蔡勇 Cai Yong], 2017, [中华实用儿科临床杂志, Chinese Journal of Applied Clinical Pediatrics], V32, P1000
[8]   Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia [J].
Chen, Jeng-Haur ;
Stoltz, David A. ;
Karp, Philip H. ;
Ernst, Sarah E. ;
Pezzulo, Alejandro A. ;
Moninger, Thomas O. ;
Rector, Michael V. ;
Reznikov, Leah R. ;
Launspach, Janice L. ;
Chaloner, Kathryn ;
Zabner, Joseph ;
Welsh, Michael J. .
CELL, 2010, 143 (06) :911-923
[9]  
[陈莉莉 Chen Lili], 2019, [临床儿科杂志, Journal of Chinical Pediatrics], V37, P457
[10]   MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
CHILLON, M ;
CASALS, T ;
MERCIER, B ;
BASSAS, L ;
LISSENS, W ;
SILBER, S ;
ROMEY, MC ;
RUIZROMERO, J ;
VERLINGUE, C ;
CLAUSTRES, M ;
NUNES, V ;
FEREC, C ;
ESTIVILL, X .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480